Global Direct-to-consumer Genetic Testing Market Expected to Witness a Sustainable Growth over 2023

Direct-to-consumer (DTC) genetic testing is a type of genetic test that is accessible directly to the consumer without having to go through a health care professional. Usually, to obtain a genetic test, health care professionals (such as doctors) acquire their patient's permission and then order the desired test. DTC genetic tests, however, allow consumers to bypass this process and order DNA tests themselves.

LPI (LP Information)' newest research report, the "Direct-to-consumer Genetic Testing Industry Forecast" looks at past sales and reviews total world Direct-to-consumer Genetic Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Direct-to-consumer Genetic Testing sales for 2023 through 2029. With Direct-to-consumer Genetic Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Direct-to-consumer Genetic Testing industry.

This Insight Report provides a comprehensive analysis of the global Direct-to-consumer Genetic Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Direct-to-consumer Genetic Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Direct-to-consumer Genetic Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Direct-to-consumer Genetic Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Direct-to-consumer Genetic Testing.

The global Direct-to-consumer Genetic Testing market size is projected to grow from US$ 1299.1 million in 2022 to US$ 4549.1 million in 2029; it is expected to grow at a CAGR of 19.6% from 2023 to 2029.

Global direct-to-consumer genetic testing main players include 23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, etc., totally accounting for about 50% of the market. North America is the largest market, with a share over 60%. As for the types of products, it can be divided into diagnostic screening, preimplantation genetic diagnosis (PGD) and relationship testing. The most common product is relationship testing, with a share over 55%. In terms of applications, it is widely used in online and offline. Online is the largest application, holding a share over 68%.

This report presents a comprehensive overview, market shares, and growth opportunities of Direct-to-consumer Genetic Testing market by product type, application, key players and key regions and countries.

Key Questions Addressed in this Report
What is the 10-year outlook for the global Direct-to-consumer Genetic Testing market?
What factors are driving Direct-to-consumer Genetic Testing market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Direct-to-consumer Genetic Testing market opportunities vary by end market size?
How does Direct-to-consumer Genetic Testing break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Request Sample Report and Full Report TOC:
https://www.lpinformationdata.com/reports/454961/direct-consumer-genetic-testing-outlook-2029

Strategic Points Covered in TOC:
Chapter 1: Scope of Direct-to-consumer Genetic Testing, Research Methodology, etc.
Chapter 2: Executive Summary, global Direct-to-consumer Genetic Testing market size (sales and revenue) and CAGR, Direct-to-consumer Genetic Testing market size by region, by type, by application, historical data from 2017 to 2023, and forecast to 2029.
Chapter 3: Direct-to-consumer Genetic Testing sales, revenue, average price, global market share, and industry ranking by company, 2017-2023
Chapter 4: Global Direct-to-consumer Genetic Testing sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Direct-to-consumer Genetic Testing market size forecast by region, by country, by type, and application.
Chapter 13: the key raw materials and key suppliers, and industry chain of Direct-to-consumer Genetic Testing.
Chapter 14: Research Findings and Conclusion

E-mail: info@lpinformationdata.com
Tel: 001-626-346-3938 (US) 00852-58080956 (HK) +86 136 6048 9451（CN）
Add: 17890 Castleton St. Suite 369 City of Industry, CA 91748 US
Website: https://www.lpinformationdata.com

LP INFORMATION (LPI) is a professional market report publisher based in America, providing high quality market research reports with competitive prices to help decision makers make informed decisions and take strategic actions to achieve excellent outcomes.We have an extensive library of reports on hundreds of technologies.Search for a specific term, or click on an industry to browse our reports by subject. Narrow down your results using our filters or sort by what's important to you, such as publication date, price, or name.

This release was published on openPR.